Frazier Healthcare Vii, L.p. - Net Worth and Insider Trading
Frazier Healthcare Vii, L.p. Net Worth
The estimated net worth of Frazier Healthcare Vii, L.p. is at least $13 Million dollars as of 2024-11-13. Frazier Healthcare Vii, L.p. is the 10% Owner of AnaptysBio Inc and owns about 595,751 shares of AnaptysBio Inc (ANAB) stock worth over $13 Million. Details can be seen in Frazier Healthcare Vii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frazier Healthcare Vii, L.p. has not made any transactions after 2017-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frazier Healthcare Vii, L.p.
Frazier Healthcare Vii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frazier Healthcare Vii, L.p. owns 3 companies in total, including Iterum Therapeutics PLC (ITRM) , AnaptysBio Inc (ANAB) , and Imago BioSciences Inc (IMGO) .
Click here to see the complete history of Frazier Healthcare Vii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Frazier Healthcare Vii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2020-01-21 | 10 percent owner |
| ANAB | AnaptysBio Inc | 2017-01-31 | 10 percent owner |
| IMGO | Imago BioSciences Inc | 2021-07-15 | 10 percent owner |
Frazier Healthcare Vii, L.p. Latest Holdings Summary
Frazier Healthcare Vii, L.p. currently owns a total of 1 stock. Frazier Healthcare Vii, L.p. owns 595,751 shares of AnaptysBio Inc (ANAB) as of January 31, 2017, with a value of $13 Million.
Latest Holdings of Frazier Healthcare Vii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAB | AnaptysBio Inc | 2017-01-31 | 595,751 | 21.52 | 12,820,562 |
Holding Weightings of Frazier Healthcare Vii, L.p.
Frazier Healthcare Vii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Frazier Healthcare Vii, L.p. has made a total of 0 transactions in AnaptysBio Inc (ANAB) over the past 5 years. The most-recent trade in AnaptysBio Inc is the acquisition of 400,000 shares on January 31, 2017, which cost Frazier Healthcare Vii, L.p. around $6 Million.
Insider Trading History of Frazier Healthcare Vii, L.p.
- 1
Frazier Healthcare Vii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Frazier Healthcare Vii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frazier Healthcare Vii, L.p. is 54.69%. GuruFocus also compares Frazier Healthcare Vii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Frazier Healthcare Vii, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frazier Healthcare Vii, L.p.'s insider trading performs compared to the benchmark.
Performance of Frazier Healthcare Vii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 33.69 | | | | | |
| Relative Return to S&P 500(%) | 29.12 | | | | | |
Frazier Healthcare Vii, L.p. Ownership Network
Ownership Network List of Frazier Healthcare Vii, L.p.
Ownership Network Relation of Frazier Healthcare Vii, L.p.
Frazier Healthcare Vii, L.p. Owned Company Details
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Frazier Healthcare Vii, L.p. is the 10 percent owner of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, Frazier Healthcare Vii, L.p. made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
Frazier Healthcare Vii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Frazier Healthcare Vii, L.p.. You might contact Frazier Healthcare Vii, L.p. via mailing address: 601 Union Street, Suite 3200, Seattle Wa 98101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
